🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

AbbVie Deutschland GmbH & Co. KG — Licensed Medicines

35 medicines held by AbbVie Deutschland GmbH & Co. KG on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 35 products held by AbbVie Deutschland GmbH & Co. KG
MedicineActive substanceLicence holderStatus
AQUIPTA 10 mg tablets
EU/1/23/1750/001-002
Atogepant monohydrate AbbVie Deutschland GmbH & Co. KG
AQUIPTA 60 mg tablets
EU/1/23/1750/003-004
Atogepant monohydrate AbbVie Deutschland GmbH & Co. KG
Constella 290 micrograms hard capsules
EU/1/12/801/001-004
Linaclotide AbbVie Deutschland GmbH & Co. KG
Ganfort 0.3 mg/ml + 5 mg/ml eye drops, solution
EU/1/06/340/001-002
Bimatoprost, Timolol AbbVie Deutschland GmbH & Co. KG
Humira 20 mg solution for injection in pre-filled syringe
EU/1/03/256/022
Adalimumab AbbVie Deutschland GmbH & Co. KG
Humira 40 mg/0.8 ml solution for injection
EU/1/03/256/1-10
Adalimumab AbbVie Deutschland GmbH & Co. KG
Humira 80 mg solution for injection in pre-filled syringe
EU/1/03/256/020
Adalimumab AbbVie Deutschland GmbH & Co. KG
Kaletra
EU/1/01/172/4-5,7-8
Lopinavir, Ritonavir AbbVie Deutschland GmbH & Co. KG
Kaletra (80 mg + 20 mg)/ml oral solution
EU/1/01/172/003
Ritonavir, Lopinavir AbbVie Deutschland GmbH & Co. KG
Kaletra 100 mg/25 mg film-coated tablets
EU/1/01/172/006
Ritonavir, Lopinavir AbbVie Deutschland GmbH & Co. KG
Lumigan 0.1 mg/ml eye drops, solution
EU/1/02/205/3-4
Bimatoprost AbbVie Deutschland GmbH & Co. KG
Lumigan 0.3 mg/ml eye drops, solution
EU/1/02/205/001-2
Bimatoprost AbbVie Deutschland GmbH & Co. KG
Maviret 100 mg/40 mg film-coated tablets
EU/1/17/1213/001
Pibrentasvir, Glecaprevir AbbVie Deutschland GmbH & Co. KG
Maviret 50 mg/20 mg coated granules in sachet
EU/1/17/1213/003
Glecaprevir, Pibrentasvir AbbVie Deutschland GmbH & Co. KG
Norvir 100 mg film-coated tablets
EU/1/96/016/005-006
Ritonavir AbbVie Deutschland GmbH & Co. KG
Norvir 100 mg powder for oral suspension
EU/1/96/016/009
Ritonavir AbbVie Deutschland GmbH & Co. KG
OZURDEX 700 micrograms intravitreal implant in applicator
EU/1/10/638/001
Dexamethasone AbbVie Deutschland GmbH & Co. KG
RINVOQ 15 mg prolonged-release tablets
EU/1/19/1404/001-005
UPADACITINIB, Upadacitinib Hemihydrate AbbVie Deutschland GmbH & Co. KG
RINVOQ 30 mg prolonged-release tablets
EU/1/19/1404/006-009
Upadacitinib Hemihydrate AbbVie Deutschland GmbH & Co. KG
RINVOQ 45 mg prolonged-release tablets
EU/1/19/1404/010-011
Upadacitinib Hemihydrate AbbVie Deutschland GmbH & Co. KG
Skyrizi 150 mg Solution for injection
EU/1/19/1361/003
RISANKIZUMAB AbbVie Deutschland GmbH & Co. KG
Skyrizi 150 mg Solution for injection
EU/1/19/1361/002
RISANKIZUMAB AbbVie Deutschland GmbH & Co. KG
Skyrizi 180 mg Solution for injection
EU/1/19/1361/007
RISANKIZUMAB AbbVie Deutschland GmbH & Co. KG
Skyrizi 180 mg solution for injection in pre-filled syringe
EU/1/19/1361/008-009
RISANKIZUMAB AbbVie Deutschland GmbH & Co. KG
Skyrizi 360 mg Solution for injection
EU/1/19/1361/005
RISANKIZUMAB AbbVie Deutschland GmbH & Co. KG
Skyrizi 55 mg solution for injection in pre-filled syringe
EU/1/19/1361/010
RISANKIZUMAB AbbVie Deutschland GmbH & Co. KG
Skyrizi 600 mg Concentrate for solution for injection
EU/1/19/1361/004
RISANKIZUMAB AbbVie Deutschland GmbH & Co. KG
Skyrizi 75 mg Solution for injection
EU/1/19/1361/001
RISANKIZUMAB AbbVie Deutschland GmbH & Co. KG
Skyrizi 90 mg Solution for injection
EU/1/19/1361/006
RISANKIZUMAB AbbVie Deutschland GmbH & Co. KG
Tepkinly 4 mg/0.8 ml solution for injection
EU/1/23/1759/001
Epcoritamab AbbVie Deutschland GmbH & Co. KG
Tepkinly 48 mg solution for injection
EU/1/23/1759/002
Epcoritamab AbbVie Deutschland GmbH & Co. KG
Venclyxto 10 mg film-coated tablets
EU/1/16/1138/001-002
Venetoclax AbbVie Deutschland GmbH & Co. KG
Venclyxto 100 mg film-coated tablets
EU/1/16/1138/005-007
Venetoclax AbbVie Deutschland GmbH & Co. KG
Venclyxto 50 mg film-coated tablets
EU/1/16/1138/003-004
Venetoclax AbbVie Deutschland GmbH & Co. KG
Xydalba
EU/1/14/986/001
Dalbavancin hcl AbbVie Deutschland GmbH & Co. KG
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 12 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.